University of California San Francisco

Give to UCSF
Advanced
1854 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics

Why Progress in Alzheimer’s Disease Treatment Has Taken 30 Years

UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.

Placeholder image

CA Governor Just Vetoed Price Caps on Insulin. Now What?

Suneil Koliwad weighs in on the state of insulin production after California Governor Gavin Newsom vetoed a law that would cap the price for consumers at $35 a month. California will focus instead on producing its own insulin for $30 per vial.

Vials of insulin in a production line.

Brief Dialysis May Be Best for Some Kidney Patients

Patients of acute kidney injury might not need as much dialysis as patients with end-stage kidney disease, and might benefit more from weaning off dialysis to avoid risk for heart disease, infection, organ damage and death.

A dialysis machine in a hospital.